<p>Bio-Rad 实验室（NYSE:BIO.B - 获取免费报告）于周四公布了季度财报。根据 Zacks 的报告，该公司本季度每股收益为 1.89 美元。Bio-Rad 实验室的净利润率为 29.42%，股本回报率为 3.86%。</p>
<p>获取 <strong>Bio-Rad 实验室</strong> 的提醒：</p>
<h2>Bio-Rad 实验室股票表现</h2>
<p>周四，BIO.B 股票在交易时段上涨了 22.45 美元，达到 299.45 美元。该公司的交易量为 3 股，而其平均交易量为 273 股。该公司的 50 日移动平均价格为 275.80 美元，200 日移动平均价格为 295.25 美元。公司的债务与股本比率为 0.16，速动比率为 4.19，流动比率为 5.62。该公司的市值为 80.8 亿美元，市盈率为 10.73，贝塔值为 0.98。Bio-Rad 实验室的年内最低价为 247.05 美元，年内最高价为 321.12 美元。</p>
<h2>Bio-Rad 实验室公司简介</h2>
<p>（获取免费报告）</p>
<p>Bio-Rad 实验室公司是一家全球领先的创新产品和系统提供商，服务于生命科学研究和临床诊断市场。该公司通过两个主要部门运营：生命科学部门，提供用于研究应用的仪器、耗材和软件；临床诊断部门，提供血型、免疫学和分子检测的质量控制材料和试剂系统。Bio-Rad 的产品组合支持广泛的应用，包括蛋白质分析、基因表达、细胞生物学和数字 PCR。</p>
<p>在生命科学部门，Bio-Rad 开发和营销电泳和成像系统、色谱仪器、实验室耗材和简化实验工作流程的软件平台等技术。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们认为比 Bio-Rad 实验室更好的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJJTy5C?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJJTy5C"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Bio-Rad 实验室吗？</h2>
<p>在考虑 Bio-Rad 实验室之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而 Bio-Rad 实验室并不在名单上。</p>
<p>虽然 Bio-Rad 实验室目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Bio-Rad实验室-B

<p>Bio-Rad 实验室（NYSE:BIO.B）报告季度每股收益为 1.89 美元，净利润率为 29.42%，股本回报率为 3.86%。该股票上涨 22.45 美元，至 299.45 美元，市值为 80.8 亿美元。该公司在生命科学和临床诊断领域运营，提供创新的产品和系统。分析师目前对该股票的评级为持有，但建议其他股票可能是更好的投资选择</p>

<p>Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) announced its quarterly earnings results on Thursday. The company reported $1.89 EPS for the quarter, Zacks reports. Bio-Rad Laboratories had a net margin of 29.42% and a return on equity of 3.86%.</p>
<div class="lb-trans"><p>Bio-Rad 实验室（NYSE:BIO.B - 获取免费报告）于周四公布了季度财报。根据 Zacks 的报告，该公司本季度每股收益为 1.89 美元。Bio-Rad 实验室的净利润率为 29.42%，股本回报率为 3.86%。</p>
</div><p>Get <strong>Bio-Rad Laboratories</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Bio-Rad 实验室</strong> 的提醒：</p>
</div><h2>Bio-Rad Laboratories Stock Performance</h2>
<div class="lb-trans"><h2>Bio-Rad 实验室股票表现</h2>
</div><p>Shares of BIO.B stock traded up $22.45 during trading hours on Thursday, reaching $299.45. The company had a trading volume of 3 shares, compared to its average volume of 273. The business has a fifty day moving average price of $275.80 and a 200-day moving average price of $295.25. The company has a debt-to-equity ratio of 0.16, a quick ratio of 4.19 and a current ratio of 5.62. The firm has a market cap of $8.08 billion, a PE ratio of 10.73 and a beta of 0.98. Bio-Rad Laboratories has a one year low of $247.05 and a one year high of $321.12.</p>
<div class="lb-trans"><p>周四，BIO.B 股票在交易时段上涨了 22.45 美元，达到 299.45 美元。该公司的交易量为 3 股，而其平均交易量为 273 股。该公司的 50 日移动平均价格为 275.80 美元，200 日移动平均价格为 295.25 美元。公司的债务与股本比率为 0.16，速动比率为 4.19，流动比率为 5.62。该公司的市值为 80.8 亿美元，市盈率为 10.73，贝塔值为 0.98。Bio-Rad 实验室的年内最低价为 247.05 美元，年内最高价为 321.12 美元。</p>
</div><h2>Bio-Rad Laboratories Company Profile</h2>
<div class="lb-trans"><h2>Bio-Rad 实验室公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Bio-Rad Laboratories, Inc is a global provider of innovative products and systems that serve the life science research and clinical diagnostics markets. The company operates through two primary segments: Life Science, which delivers instruments, consumables and software for research applications, and Clinical Diagnostics, which offers quality control materials and reagent systems for blood typing, immunology and molecular testing. Bio-Rad's product portfolio supports a wide range of applications, including protein analysis, gene expression, cell biology and digital PCR.</p>
<div class="lb-trans"><p>Bio-Rad 实验室公司是一家全球领先的创新产品和系统提供商，服务于生命科学研究和临床诊断市场。该公司通过两个主要部门运营：生命科学部门，提供用于研究应用的仪器、耗材和软件；临床诊断部门，提供血型、免疫学和分子检测的质量控制材料和试剂系统。Bio-Rad 的产品组合支持广泛的应用，包括蛋白质分析、基因表达、细胞生物学和数字 PCR。</p>
</div><p>In the Life Science segment, Bio-Rad develops and markets technologies such as electrophoresis and imaging systems, chromatography instruments, laboratory consumables and software platforms that streamline experimental workflows.</p>
<div class="lb-trans"><p>在生命科学部门，Bio-Rad 开发和营销电泳和成像系统、色谱仪器、实验室耗材和简化实验工作流程的软件平台等技术。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Bio-Rad Laboratories</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Bio-Rad 实验室更好的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJJTy5C" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=BIO.B"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bio-Rad Laboratories Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Bio-Rad 实验室吗？</h2>
</div><p>Before you consider Bio-Rad Laboratories, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Bio-Rad 实验室之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户在更广泛的市场注意到之前立即购买的股票……而 Bio-Rad 实验室并不在名单上。</p>
</div><p>While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Bio-Rad 实验室目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Bio-Rad Lab-B（NYSE:BIO.B）公布财报结果